Accéder au contenu
Merck
  • Hesperetin induces the apoptosis of hepatocellular carcinoma cells via mitochondrial pathway mediated by the increased intracellular reactive oxygen species, ATP and calcium.

Hesperetin induces the apoptosis of hepatocellular carcinoma cells via mitochondrial pathway mediated by the increased intracellular reactive oxygen species, ATP and calcium.

Medical oncology (Northwood, London, England) (2015-03-05)
Jixiang Zhang, Jia Song, Dandan Wu, Jing Wang, Weiguo Dong
RÉSUMÉ

Hesperetin, a flavonoid from citrus fruits, has been proved to possess biological activity on various types of human cancers. However, few related studies on hepatocellular carcinoma are available. In this study, we aimed to investigate the effect of hesperetin on hepatocellular carcinoma cells in vitro and in vivo and clarify its potentially specific mechanism. Compared with the control group, the proliferations of hepatocellular carcinoma cells in hesperetin groups were significantly inhibited (P < 0.05), and a dose- and time-dependent inhibition of cell viability was observed. When pretreated with H2O2 (1 mM) or N-acetyl-L-cysteine (5 mM), the inhibition of cell viability by hesperetin was enhanced or reduced, respectively (P < 0.05). Similarly, the levels of intracellular ROS, ATP and Ca(2+) changed in different groups (P < 0.05). The results of Hoechst 33258 staining showed that the percentages of apoptotic cells in hesperetin groups are remarkably higher than that in control group (P < 0.05). And the results of Western blot showed that hesperetin caused an increase in the levels of cytosolic AIF, cytosolic Apaf-1, cytosolic Cyt C, caspase-3, caspase-9 and Bax and a decrease in that of Bcl-2, mitochondrial AIF, mitochondrial Apaf-1 and mitochondrial Cyt C (P < 0.05). Meanwhile, hesperetin significantly inhibited the growth of xenograft tumors. Our study suggests that hesperetin could inhibit the proliferation and induce the apoptosis of hepatocellular carcinoma via triggering the activation of the mitochondrial pathway by increasing the levels of intracellular ROS, ATP and Ca(2+).

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Peroxyde d'hydrogène solution, contains inhibitor, 30 wt. % in H2O, ACS reagent
Sigma-Aldrich
Peroxyde d'hydrogène solution, 30 % (w/w) in H2O, contains stabilizer
Sigma-Aldrich
Fluorure de phénylméthanesulfonyle, ≥98.5% (GC)
Sigma-Aldrich
Peroxyde d'hydrogène solution, 50 wt. % in H2O, stabilized
Sigma-Aldrich
Peroxyde d'hydrogène solution, 30% (w/w), puriss. p.a., reag. ISO, reag. Ph. Eur.
Millipore
Peroxyde d'hydrogène solution, 3%, suitable for microbiology
Supelco
Peroxyde d'hydrogène solution, ≥30%, for trace analysis
Sigma-Aldrich
Peroxyde d'hydrogène solution, contains ~200 ppm acetanilide as stabilizer, 3 wt. % in H2O
Sigma-Aldrich
Fluorure de phénylméthanesulfonyle, ≥99.0% (T)
Sigma-Aldrich
Peroxyde d'hydrogène solution, contains inhibitor, 35 wt. % in H2O
Sigma-Aldrich
Peroxyde d'hydrogène solution, purum p.a., ≥35% (RT)
Sigma-Aldrich
Peroxyde d'hydrogène solution, 34.5-36.5%
Supelco
Peroxyde d'hydrogène solution, 30 % (w/w), for ultratrace analysis
Sigma-Aldrich
Peroxyde d'hydrogène solution, contains inhibitor, 30 wt. % in H2O, meets USP testing specifications
Sigma-Aldrich
Hesperetin, ≥95%
Sigma-Aldrich
(Tyr[SO3H]27)Cholecystokinin fragment 26-33 Amide, ≥97% (HPLC), powder